课题基金 / 基金详情

CIVICS)PROGRAM - SARS-CoV-2 STUDIES

CIVICS)PROGRAM - SARS-CoV-2 STUDIES
CIVICS) 计划 - SARS-CoV-2 研究
批准号:
10269386
负责人:
FLORIAN KRAMMER
金额:
$734.26万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-10 至 2022-03-31

项目摘要

项目成果

FLORIAN KRAMMER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This contract supports the design and evaluation of innovative vaccine candidates and delivery platforms that aim to achieve durable, robust and broadly protective immunity. Activities may include immunologic analyses to inform vaccine design and identify surrogates/correlates of protection; in vitro and in vivo immunogenicity and efficacy testing; assay and reagent development; and clinical studies and trials. Additional studies are being conducted to evaluate the immune response to SARS-CoV-2 infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF A VACCINE CANDIDATE FOR CORONAVIRUSES
CIVICS PROGRAM - SARS-CoV-2 STUDIES
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA RESEARCH
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER
海外基金